Effectiveness and safety of vonoprazan-based regimens compared with those of proton pump inhibitor (PPI)–based regimens as first-line agents for Helicobacter pylori: a meta-analysis of randomized clinical trials
Yingchao Sun, Lei Yue, Weiling Hu
Topics & Concepts
Proton-pump inhibitorHelicobacter pyloriMeta-analysisMedicineInternal medicineRandomized controlled trialClinical trialFirst linePharmacologyGastroenterologyHelicobacter pylori-related gastroenterology studiesGastroesophageal reflux and treatmentsClostridium difficile and Clostridium perfringens research